The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR- 2 Regulated AKT/mTOR/P70S6K Signaling Pathways
Open accessAbstract
Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995) · Nature · doi:10.1038/376037a0 · Cited by 3,979
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90541-3 · Cited by 2,367
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Kaufmann, S. H., Desnoyers, S., Ottaviano, Y. L., Davidson, N. E., & Poirier, G. G. (1993) · PubMed · Cited by 1,889
Review of the biology of quercetin and related bioflavonoids
Formica, J. V., & Regelson, W. (1995) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00077-1 · Cited by 1,765
Breast Cancer Research and Treatment
Alexander, M. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006151427889 · Cited by 997
Poly(ADP-Ribose) in the Cellular Response to DNA Damage
Berger, N. A. (1985) · Radiation Research · doi:10.2307/3576299 · Cited by 775
Multitargeted cancer prevention by quercetin
Murakami, A., Ashida, H., & Terao, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.046 · Cited by 721
Journal of Thrombosis and Haemostasis
(2023) · Journal of Thrombosis and Haemostasis · doi:10.1111/(issn)1538-7836 · Cited by 555
Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
Yap, T. A., Garrett, M. D., Walton, M. I., Raynaud, F., de Bono, J. S., & Workman, P. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.004 · Cited by 543
VEGF Receptor Signaling in Tumor Angiogenesis
McMahon, G. (2000) · The Oncologist · doi:10.1634/theoncologist.5-2004-3 · Cited by 519
Quercetin: potentials in the prevention and therapy of disease
Bischoff, S. C. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32831394b8 · Cited by 486
The Role of Vascular Endothelial Growth Factor in Angiogenesis
Ferrara, N., & Gerber, H.-P. (2001) · Acta Haematologica · doi:10.1159/000046610 · Cited by 451
Neovasculature induced by vascular endothelial growth factor is fenestrated.
Roberts, W. G., & Palade, G. E. (1997) · PubMed · Cited by 446
Vasculogenesis and Angiogenesis
Patan, S. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_1 · Cited by 430
Yi, T., Cho, S.-G., Yi, Z., Pang, X., Rodriguez, M., Wang, Y., Sethi, G., Aggarwal, B. B., & Liu, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0124 · Cited by 352
DVORAK, H. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01361.x · Cited by 296
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
Cao, Y. (2009) · Science Signaling · doi:10.1126/scisignal.259re1 · Cited by 289
Anti-Cancer Agents in Medicinal Chemistry
(2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/acamc-18715206-578 · Cited by 239
Pang, X., Yi, Z., Zhang, X., Sung, B., Qu, W., Lian, X., Aggarwal, B. B., & Liu, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0755 · Cited by 213
Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Pratheeshkumar, P., Sreekala, C., Zhang, Z., Budhraja, A., Ding, S., Son, Y.-O., Wang, X., Hitron, A., Hyun-Jung, K., Wang, L., et al. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833035 · Cited by 178
Self-citationTumor angiogenesis – A potential target in cancer chemoprevention
Bhat, T. A., & Singh, R. P. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.08.032 · Cited by 160
Inhibition of tumor progression by naturally occurring terpenoids
Kuttan, G., Pratheeshkumar, P., Manu, K. A., & Kuttan, R. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2011.559476 · Cited by 143
Self-citationmTOR inhibitors in the treatment of cancer
Fasolo, A., & Sessa, C. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.11.1717 · Cited by 138
Tufan, A. C., & Şatıroğlu-Tufan, N. L. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054064624 · Cited by 133
Seeliger, H., Guba, M. O., Kleespies, A., Jauch, K., & Bruns, C. J. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9077-8 · Cited by 121
A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling
Chen, J., & Fang, Y. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01263-7 · Cited by 120
Dietary Flavonoids as Cancer Prevention Agents
Yao, H., Xu, W., Shi, X., & Zhang, Z. (2011) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2011.551317 · Cited by 117
Self-citationApigenin Induces Apoptosis in Human Leukemia Cells and Exhibits Anti-Leukemic Activity In Vivo
Budhraja, A., Gao, N., Zhang, Z., Son, Y., Cheng, S., Wang, X., Ding, S., Hitron, J. A., Chen, G., Luo, J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0343 · Cited by 106
Self-citationActivation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma
Li, W. (1994) · Oncology Reports · doi:10.3892/or_00000064 · Cited by 90
Wang, S., Xu, M., Li, F., Wang, X., Bower, K. A., Frank, J. A., Lu, Y., Chen, G., Zhang, Z., Ke, Z., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1902-7 · Cited by 78
Self-citationRole and Mechanism of Arsenic in Regulating Angiogenesis
Liu, L.-Z., Jiang, Y., Carpenter, R. L., Yi, J., Peiper, S. C., & Jiang, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020858 · Cited by 75
Journal of Environmental Science and Health - Part C
Woo, Y.-H., Fan, A. M., Fu, P.-J., & Vinceti, M. (2011) · Cited by 66
Endothelial p70 S6 Kinase 1 in Regulating Tumor Angiogenesis
Liu, L.-Z., Zheng, J. Z., Wang, X., & Jiang, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0819 · Cited by 45
Self-citationPratheeshkumar, P., & Kuttan, G. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2010.520017 · Cited by 36
Self-citationPratheeshkumar, P., & Kuttan, G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.041 · Cited by 19
Self-citation
Cited by
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
Tang, S.-M., Deng, X.-T., Zhou, J., Li, Q.-P., Ge, X.-X., & Miao, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109604 · Cited by 654
Flavonoids as prospective compounds for anti-cancer therapy
Ravishankar, D., Rajora, A. K., Greco, F., & Osborn, H. M. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.10.004 · Cited by 572
Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
Hashemzaei, M., Far, A. D., Yari, A., Heravi, R. E., Tabrizian, K., Taghdisi, S. M., Sadegh, S. E., Tsarouhas, K., Kouretas, D., Tzanakakis, G., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5766 · Cited by 520
Srivastava, S., Somasagara, R. R., Hegde, M., Nishana, M., Tadi, S. K., Srivastava, M., Choudhary, B., & Raghavan, S. C. (2016) · Scientific Reports · doi:10.1038/srep24049 · Cited by 483
Metadata
- Authors
- Pratheeshkumar, P., Budhraja, A., Son, Y.-O., Wang, X., Zhang, Z., Ding, S., Wang, L., Hitron, A., Lee, J.-C., Xu, M., Chen, G., Luo, J., & Shi, X.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-18
- Volume
- 7
- Issue
- 10
- Pages
- e47516
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2030104903
- Cited by
- 307
- References
- 40
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.